Home3696 • HKG
add
Insilico Medicine Cayman TopCo
Previous close
$44.90
Day range
$43.50 - $48.46
Year range
$29.98 - $48.46
Market cap
26.20B HKD
Avg Volume
2.25M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 13.73M | -54.00% |
Operating expense | 22.69M | -14.83% |
Net income | -9.61M | -339.29% |
Net profit margin | -69.98 | -620.30% |
Earnings per share | — | — |
EBITDA | -10.57M | -555.35% |
Effective tax rate | -0.21% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 212.63M | — |
Total assets | 241.31M | — |
Total liabilities | 922.68M | — |
Total equity | -681.36M | — |
Shares outstanding | 77.27M | — |
Price to book | -5.09 | — |
Return on assets | -11.58% | — |
Return on capital | 4.14% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -9.61M | -339.29% |
Cash from operations | -18.42M | -13.79% |
Cash from investing | 1.20M | 128.40% |
Cash from financing | 60.19M | 13,718.44% |
Net change in cash | 43.09M | 308.18% |
Free cash flow | -4.80M | — |
About
Insilico Medicine is a biotechnology company headquartered in Boston, Massachusetts, with additional facilities in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield. The company combines genomics, big data analysis, and deep learning for in silico drug discovery. Wikipedia
Founded
2014
Website
